Fresh Recalls

FDAClass II · Drug · Recall D-0522-2026 · Recalled May 13, 2026

Duloxetine Delayed-Release Capsules USP recall — Breckenridge Pharmaceutical, Inc.

Agency report date: May 13, 2026.

1. Compare your item

This notice names a product; your particular item is not yet verified. Compare every applicable model, serial, lot, production-date or model-year boundary below.

Product named
Duloxetine Delayed-Release Capsules USP
Company / brand
Breckenridge Pharmaceutical
Lot / serial / date codes
Lot: 241069C, Exp 05/31/2027
Distribution
Nationwide in the USA
Agency product description and boundaries

Duloxetine Delayed-Release Capsules USP, 60mg, Rx Only, 90-count bottle, Mfr. by Towa Pharmaceutical Eurpoe S.L., Martorelles, (Barcelona), Spain, Dist. by. Breckenridge Pharmaceutical, Inc., Berkely Heights, NJ 07922, NDC 51991-748-90.

Still to verify: match the label on your item with the full official notice, including any exclusions, tables and photos. Some identifiers appear only on the agency website and are absent from this data feed. A missing field does not mean all versions are affected.

If your lot or date falls outside a stated range, this notice has not established that your item is affected. This is not a finding about other recalls or product safety.

2. Agency hazard and consumer action

FDA reports: CGMP Deviations; presence of N-nitroso-duloxetine impurity above the FDA recommended limit

No consumer remedy instructions are supplied in this record. Check the official notice and listed company contact for the agency’s current instructions.

Class II: may cause temporary or medically reversible health consequences.

Affected product: Duloxetine Delayed-Release Capsules USP

3. Open the official notice or contact

Official recall ID
D-0522-2026
Brand
Breckenridge Pharmaceutical
Classification
Class II
Units affected
165,761 90-count bottles
Recall status
Ongoing
Initiated
Voluntary: Firm initiated

Affected products

Companies & origin

Recalling firm location
Berkeley Heights, NJ, United States
Firm address
200 Connell Dr Ste 4200, 07922-2805

Identifying details (verbatim from the notice)

Product codes / lots
Lot: 241069C, Exp 05/31/2027
Distribution
Nationwide in the USA
Firm notified the public via
Letter
FDA event ID
98803
Recall initiated
April 21, 2026
FDA classified
May 6, 2026
FDA report date
May 13, 2026
Verify with the official sources:

Found something wrong or missing? Report a data error.

Source: U.S. Food & Drug Administration. Agency excerpts come from the public data feed and may omit tables or later changes; the linked government source is authoritative. Source last checked September 7, 2026 at 6:00 AM UTC. Record retrieved August 11, 2026 at 6:00 PM UTC.

Report a data error on this page